FactorPad
Build a Better Process

Stock Risk Measures for Nevro Corp

A quantitative factor review as of June 30, 2021.
  1. Company Info - Description, identity and sector data.
  2. Share Data - Stock earnings and key dates.
  3. Market Risk - Beta, size, liquidity and momentum measures.
  4. Financial Risk - Earnings and dividends.
face pic by Paul Alan Davis, CFA
Updated: July 06, 2021
See how we arrive at an overall risk score of 61 for NVRO below.

/ factorpad.com / stocks / f61kxg.html


An ad-free and cookie-free website.


NVRO Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Nevro Corp. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how NVRO stock compares to 2,000+ US-based stocks, and to peers in the Manufacturing sector and Surgical and Medical Instrument Manufacturing industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Company logo Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based, non-pharmacologic neuromodulation platform for the treatment of chronic pain. HF10 therapy has demonstrated the ability to reduce or eliminate opioids in =65% of patients across six peer-reviewed clinical studies. The Senza® System, Senza II™ System, and the Senza® Omnia™ System are the only SCS systems that deliver Nevro's proprietary HF10® therapy. Senza, Senza II, Senza Omnia, HF10, Nevro and the Nevro logo are trademarks of Nevro Corp.

Identity

Sector and Industry

Share Data

Shares

Earnings and Dividends

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

/ factorpad.com / stocks / f61kxg.html


NVRO stock risk
NEVRO CORP stock beta
NVRO risk report
NVRO f61kxg
NVRO risk analysis
NVRO volatility
NEVRO CORP credit risk
NVRO liquidity risk
NVRO leverage
NVRO valuation
NVRO systematic risk
NVRO specific risk
NEVRO CORP volatility
NVRO analysis
NVRO financial ratio

A newly-updated free resource. Connect and refer a friend today.